About Indonesia IMTC
All About TB & MDR TB
TB Article Update
Case Study
Aks The Expert
Media Center
SIGN IN
SELECT LANGUAGE
 
WELCOME TO IMTC

MDR-TB is a form of TB that is resistant to at least the two medicines-- rifampicin and isoniazid. Compared to 6-9 months treatment for drug susceptible TB, it can take up to two years to treat MDR-TB and this difficult-to-treat TB costs at least 100 times more! Anti-tuberculosis drug resistance is a major public health problem that threatens progress made in TB care and control worldwide. Drug can resistance arise due to improper use of antibiotics in drug-susceptible TB patients; administration of improper treatment regimens and failure to ensure that patients complete the whole course of treatment. A patient who develops active disease with a drug-resistant TB strain can transmit this form of TB to other individuals.

MEMBER LOG IN
LOG IN
RESET Password


Forgot Password
REQUEST FOR INVITATION

Membership of IMTC is open to any healthcare professionals in the Asia-Pacific region who manage patients with
MDR-TB, including:

• Medical Specialist • Public Health Worker
• General Practitioners • Other Health Care Worker
• Nurse • Pharmacists

Access to the IMTC website is for registered users only.
Registration for IMTC is available to healthcare professionals authorised to practice in their country.

Ready to join IMTC?

REGISTRATION FORM